Amin Raj M, Puvanesarajah Varun, Chaudhry Yash P, Best Matthew J, Rao Sandesh S, Frank Steven M, Hasenboehler Erik A
Department of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA 94305, United States.
Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.
World J Orthop. 2021 May 18;12(5):292-300. doi: 10.5312/wjo.v12.i5.292.
Maximum surgical blood order schedules were designed to eliminate unnecessary preoperative crossmatching prior to surgery in order to conserve blood bank resources. Most protocols recommend type and cross of 2 red blood cell (RBC) units for patients undergoing surgery for treatment of hip fracture. Preoperative hemoglobin has been identified as the strongest predictor of inpatient transfusion, but current maximum surgical blood order schedules do not consider preoperative hemoglobin values to determine the number of RBC units to prepare prior to surgery.
To determine the preoperative hemoglobin level resulting in the optimal 2:1 crossmatch-to-transfusion (C:T) ratio in hip fracture surgery patients.
In 2015 a patient blood management (PBM) program was implemented at our institution mandating a single unit-per-occurrence transfusion policy and a restrictive transfusion threshold of < 7 g/dL hemoglobin in asymptomatic patients and < 8 g/dL in those with refractory symptomatic anemia or history of coronary artery disease. We identified all hip fracture patients between 2013 and 2017 and compared the preoperative hemoglobin which would predict a 2:1 C:T ratio in the pre PBM and post PBM cohorts. Prediction profiling and sensitivity analysis were performed with statistical significance set at < 0.05.
Four hundred and ninety-eight patients who underwent hip fracture surgery between 2013 and 2017 were identified, 291 in the post PBM cohort. Transfusion requirements in the post PBM cohort were lower (51% 33%, < 0.0001) than in the pre PBM cohort. The mean RBC units transfused per patient was 1.15 in the pre PBM cohort, compared to 0.66 in the post PBM cohort ( < 0.001). The 2:1 C:T ratio (inpatient transfusion probability of 50%) was predicted by a preoperative hemoglobin of 12.3 g/dL [area under the curve (AUC) 0.78 (95% confidence interval (CI), 0.72-0.83), Sensitivity 0.66] in the pre PBM cohort and 10.7 g/dL [AUC 0.78 (95%CI, 0.73-0.83), Sensitivity 0.88] in the post PBM cohort. A 50% probability of requiring > 1 RBC unit was predicted by 11.2g/dL [AUC 0.80 (95%CI, 0.74-0.85), Sensitivity 0.87] in the pre PBM cohort and 8.7g/dL [AUC 0.78 (95%CI, 0.73-0.83), Sensitivity 0.84] in the post-PBM cohort.
The hip fracture maximum surgical blood order schedule should consider preoperative hemoglobin in determining the number of units to type and cross prior to surgery.
制定最大手术用血计划是为了在手术前消除不必要的交叉配血,以节省血库资源。大多数方案建议,接受髋部骨折手术治疗的患者备2个单位红细胞(RBC)的血型及交叉配血。术前血红蛋白已被确定为住院输血最强的预测指标,但目前的最大手术用血计划在确定术前准备的RBC单位数量时并未考虑术前血红蛋白值。
确定髋部骨折手术患者中能产生最佳2:1交叉配血与输血(C:T)比例的术前血红蛋白水平。
2015年,我们机构实施了一项患者血液管理(PBM)计划,规定每次输血1个单位的政策以及无症状患者血红蛋白<7 g/dL、难治性症状性贫血或有冠状动脉疾病史患者血红蛋白<8 g/dL的限制性输血阈值。我们确定了2013年至2017年间所有髋部骨折患者,并比较了PBM实施前和实施后队列中能预测2:1 C:T比例的术前血红蛋白水平。进行预测分析和敏感性分析,设定统计学显著性为<0.05。
确定了2013年至2017年间接受髋部骨折手术的498例患者,PBM实施后队列中有291例。PBM实施后队列的输血需求低于PBM实施前队列(51%对33%,<0.0001)。PBM实施前队列中每位患者平均输注的RBC单位数为1.15,而PBM实施后队列为0.66(<0.001)。PBM实施前队列中,术前血红蛋白12.3 g/dL可预测2:1 C:T比例(住院输血概率为50%)[曲线下面积(AUC)0.78(95%置信区间(CI),0.72 - 0.83),敏感性0.66],PBM实施后队列为10.7 g/dL [AUC 0.78(95%CI,0.73 - 0.83),敏感性0.88]。PBM实施前队列中,预测需要>1个RBC单位的概率为50%时对应的血红蛋白水平为11.2g/dL [AUC 0.80(95%CI,0.74 - 0.85),敏感性0.87],PBM实施后队列为8.7g/dL [AUC 0.78(95%CI,0.73 - 0.83),敏感性0.84]。
髋部骨折最大手术用血计划在确定术前血型鉴定和交叉配血的单位数量时应考虑术前血红蛋白水平。